Skip to search.
 FTSE 100 Down 3.03%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
35.21 Down 0.49(1.37%) 1 Sep 21:00
|After Hours: : 35.21 0.00 (0.00%) 1 Sep 22:10
Add to Portfolio
Prev Close:35.70
Open:34.82
Bid:35.01 x 300
Ask:37.21 x 200
1y Target Est:39.46
Beta:0.297722
Earnings Date:4 Nov - 9 Nov (Est.)
Day's Range:34.20 - 35.84
52wk Range:11.33 - 37.39
Volume:1,260,726
Avg Vol (3m):1,269,360
Market Cap:1.46b
P/E (ttm):N/A
EPS (ttm):-4.29
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTDown 1.37%1.46b
ISISDown 2.85%5.85b
ALNYDown 4.87%8.28b
GSKDown 3.57%95.40b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,364.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-4.86
Quarterly EPS Est (Sep-15) :-1.19
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):36.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback